InCytu, Inc. is an applied biotechnology company developing cell therapy delivery devices which promote targeted tissue healing/regeneration or modulate the immune system.
Able to harness and amplify the body’s natural regenerative processes, InCytu’s breakthrough Cellarium™ platform technology was first developed in Professor David Mooney’s lab at Harvard University. Cellarium’s novel pre-programmed polymer system locally delivers physiologically correct cells and factors so that the cells integrate naturally into damaged or deficient tissues.
Driven by a seasoned senior management team with deep experience in cell therapies, InCytu is developing simple, yet elegant products to bring this revolutionary technology to underserved patient populations. Our initial product (Cellarium TR) restores healthy blood vessels to ischemic wounds and accelerates the local tissue regeneration and healing. Cellarium TR has successfully demonstrated efficacy in both open surgical and topical applications.
Contact us for more information.
